GMP Cytokines Market Size, Share and Industry Trends Forecast 2027

Posted by mahesh on October 19th, 2022

According to our new research study on “GMP Cytokines Market Forecast to 2027 – COVID-19 Impact and Analysis – by Type and Application,” the market is expected to reach US$ 158.13 million in 2027 from US$ 84.72 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report highlights key driving factors and prominent market players along with their developments in the market.

Biomarkers are used to refine diagnosis, comprehend the progress of diseases, and monitor the efficiency of treatment based on physiological, anatomical, and molecular parameters associated with the severity of specific disease states. Cytokines can also be used as biomarkers for some of the autoimmune disorders. Moreover, the involvement of market players for the development and research on cytokines biomarkers is expected to offer market growth in years to come. For instance, in March 2020, Evelo Biosciences, Inc., a clinical stage biotechnology company, announced results of its cytokines candidate EDP1815 as a biomarker for inflammatory diseases, such as psoriasis. Additionally, in September 2020, Sonnet BioTherapeutics Holdings, Inc. announced positive results of its IL-12 candidate, SON-1010 for the efficacy over cancer. Moreover, the drug can also be used as biomarker for cancer. Further, in May 2020, Cerecor Inc. and Myriad Genetics Inc. announced results of collaborative study about CERC-002 cytokines as biomarkers for acute respiratory distress syndrome during COVID-19. All these developments are likely to reshape the GMP cytokines market during the forecast period.

Request Sample PDF Brochure – https://www.theinsightpartners.com/sample/TIPRE00008212/

Geographically, the GMP cytokines market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America held the largest market share in 2019. In North America, the US is the largest market for GMP cytokines. The growth of the market in the region is attributed to the presence of key market players and their product development. In addition, the escalating prevalence of chronic conditions is further contributing to the growth of the market in North America.

Market leaders operating in the market have undertaken various organic growth strategies in the GMP cytokines  market. The GMP cytokines  majorly consists of the players such Miltenyi Biotec, Sino Biological Inc., ABCAM, PeproTech Inc., Akron Biotech, CellGenix GmbH, BIO-TECHNE CORPORATION, CREATIVE BIOARRAY, Proteintech Group, Inc., and REPROCELL Inc among others. Some of the activities undertaken by the company, which have promoted its growth are, product launch, Approvals, partnership and strategy and business planning. Companies such as Akron Biotech. CellGenix GmbH, Proteintech Group, Inc., and others have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. 

Segmentation

By Type

  •                      TNF
  •                      Interleukin
  •                      Growth Factor
  •                      Others

By Application

  •                      Cell and Gene Therapy
  •                      Tissue-Engineered Products
  •                      Others

By Geography

  •                      North America
  •                      Europe
  •                      Asia Pacific (APAC)
  •                      Middle East and Africa (MEA)
  •                      South and Central America

Latest Industry News

In Apr-2020        

Proteintech Group, Inc. received ISO 13485 Certification for Its HumanKine Human Cell-expressed Cytokines and Growth Factors.

In  Oct-2020       

Akron Biotech acquired Cytiva, a global life sciences leader. This acquisition is expected to help Akron Biotech enhance its cGMP-compliant solutions to support advanced therapy development. The installation of FlexFactory will enable the company to ease constraints in the supply of critical materials for cell and gene therapy manufacturing

In Oct-2020        

CellGenix has reconstructed and expanded its production facility for cytokines and implemented a state-of-the-art automated filling and freeze-drying line.

In Jun-2019        

Proteintech Group, Inc. started its brand new state-of-the-art Good Manufacturing Practice (GMP)-grade laboratory, and it is located at the company's headquarters in Rosemont, IL.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Like it? Share it!


mahesh

About the Author

mahesh
Joined: September 20th, 2022
Articles Posted: 71

More by this author